Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — breast cancer prevention

Most people associate iodine exclusively with thyroid health — but this essential mineral plays a far broader role in the body. From breast tissue and ovarian function to fetal brain development and endometrial health, iodine is active in virtually every organ system. Deficiency is more widespread than commonly recognised, and standard thyroid blood tests cannot reliably detect it. This guide explores the extrathyroidal roles of iodine, the difference between iodide and molecular iodine, the controversy around dosing, and why testing urinary iodine is the most accurate way to assess your status.

Single nucleotide variations (SNVs) in the enzymes that metabolise estrogen can significantly alter breast cancer risk — in some cases by as much as 12-fold when multiple variants combine. In this detailed scientific overview, Jillian Harrington PhD of ZRT Laboratory explains how variations in CYP11A1, CYP19A1 (aromatase), CYP1B1, COMT and MnSOD affect the estrogen metabolism pathway, why catechol estrogens are dangerous, and how methylation testing can reveal individual vulnerability.

What do heavy metals, neurotransmitters and hormone imbalances have in common? In this detailed case study, Dr. Kate Placzek examines Loretta — a 62-year-old postmenopausal woman with breast cancer — and shows how comprehensive testing can reveal the complex biochemical picture behind a cancer diagnosis. A compelling read for anyone interested in the role of hormones and toxic exposure in breast health.

Breast cancer is not one disease — it encompasses many distinct types with different attributes, degrees of invasiveness and treatment responses. Understanding the difference between invasive and non-invasive cancers, what hormone receptor status means, and which risk factors are modifiable can help women make more informed decisions about screening, lifestyle and hormone health. This article provides a clear, evidence-based overview.

Breast cancer rates have risen from 1 in 30 to 1 in 8 women over the past 30 years — yet the focus remains on treatment rather than prevention. Drawing on 35 years of clinical experience and infrared thermography, this article makes the case that environmental toxins, xenoestrogens, hormone imbalance and lifestyle factors may account for 91–93% of breast cancer risk. Prevention, not just awareness, is the real cure.